Xia Howard H. 4
4 · COHERENT CORP. · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Coherent (COHR) Director Howard Xia Exercises Options, Sells Shares
What Happened
- Xia Howard H., a director of Coherent Corp. (COHR), exercised stock options to acquire 4,240 shares (1,000 on 2026-03-16 and 3,240 on 2026-03-17) at $21.67 per share (total cash paid ≈ $91,881). He sold a matching 4,240 shares in open-market transactions on March 16–17, 2026 for aggregate proceeds of about $1,040,943. The filing shows additional zero-dollar derivative "Disposed" entries corresponding to the exercised amounts.
Key Details
- Transaction dates and prices:
- 2026-03-16: Exercised 1,000 options @ $21.67 (acquired for $21,670); sold 1,000 shares @ $258.00 (proceeds $258,000); derivative disposal 1,000 @ $0 reported.
- 2026-03-17: Exercised 3,240 options @ $21.67 (acquired for $70,211); sold 1,000 @ $245.57 (proceeds $245,570), 1,000 @ $244.46 (proceeds $244,460), and 1,240 @ $236.22 (proceeds $292,913); derivative disposal 3,240 @ $0 reported.
- Aggregate: Acquired 4,240 shares via option exercise (≈ $91,881 cash paid); sold 4,240 shares for ≈ $1,040,943.
- Shares owned after the reported transactions: not specified in the provided data.
- Footnote: The options exercised vested in four equal annual installments beginning August 17, 2017 (per footnote F1).
- Filing: Report lists transaction period Mar 16–17, 2026 and was filed on Mar 18, 2026 (no late-filing flag shown).
Context
- This pattern (exercise of options followed by immediate open-market sales) is commonly a cashless/net exercise or exercise-plus-sell to cover the exercise cost and taxes; the zero-dollar derivative "Disposed" lines in the filing reflect related net settlement/withholding reporting. These transactions are routine director option exercises and sales and do not, by themselves, indicate a company-wide change in outlook.
Insider Transaction Report
Form 4
COHERENT CORP.COHR
Xia Howard H.
Director
Transactions
- Exercise/Conversion
Common Stock
2026-03-16$21.67/sh+1,000$21,670→ 51,298 total - Sale
Common Stock
2026-03-16$258.00/sh−1,000$258,000→ 50,298 total - Exercise/Conversion
Common Stock
2026-03-17$21.67/sh+3,240$70,211→ 53,538 total - Sale
Common Stock
2026-03-17$245.57/sh−1,000$245,570→ 52,538 total - Sale
Common Stock
2026-03-17$244.46/sh−1,000$244,460→ 51,538 total - Sale
Common Stock
2026-03-17$236.22/sh−1,240$292,913→ 50,298 total - Exercise/Conversion
Option (Right to Buy)
[F1]2026-03-16−1,000→ 5,240 totalExercise: $21.67Exp: 2026-08-20→ Common Stock (1,000 underlying) - Exercise/Conversion
Option (Right to Buy)
[F1]2026-03-17−3,240→ 2,000 totalExercise: $21.67Exp: 2026-08-20→ Common Stock (3,240 underlying)
Footnotes (1)
- [F1]These options vested in four equal annual installments beginning on August 17, 2017.
Signature
/s/ Christopher M. Forrester, Attorney-in-Fact|2026-03-18